Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer's Disease

Full text
Show less -
Silva, Aderbal R. T. [1] ; Feio Santos, Ana Cecilia [1] ; Farfel, Jose M. [2, 3] ; Grinberg, Lea T. [2, 4] ; Ferretti, Renata E. L. [2, 3] ; Froes Marques Campos, Antonio Hugo Jose [5] ; Cunha, Isabela Werneck [5] ; Begnami, Maria Dirlei [5] ; Rocha, Rafael M. [6] ; Carraro, Dirce M. [6] ; de Braganca Pereira, Carlos Alberto [7] ; Jacob-Filho, Wilson [2, 3] ; Brentani, Helena [1]
Total Authors: 13
[1] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Lab Clin Pathol, Lab Med Invest 23, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Med, LIM 22, Brazilian Brain Bank, Aging Brain Study Grp, Sao Paulo - Brazil
[3] Univ Sao Paulo, Sch Med, Div Geriatr, Sao Paulo - Brazil
[4] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA - USA
[5] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo - Brazil
[6] AC Camargo Canc Ctr, Res Ctr CIPE, Sao Paulo - Brazil
[7] Univ Sao Paulo, Math & Stat Inst, Sao Paulo - Brazil
Total Affiliations: 7
Document type: Journal article
Source: PLoS One; v. 9, n. 6 JUN 17 2014.
Web of Science Citations: 32

Alzheimer's disease (AD) is characterized by progressive cognitive decline associated with a featured neuropathology (neuritic plaques and neurofibrillary tangles). Several studies have implicated oxidative damage to DNA, DNA repair, and altered cell-cycle regulation in addition to cell death in AD post-mitotic neurons. However, there is a lack of studies that systematically assess those biological processes in patients with AD neuropathology but with no evidence of cognitive impairment. We evaluated markers of oxidative DNA damage (8-OHdG, H2AX), DNA repair (p53, BRCA1, PTEN), and cell-cycle (Cdk1, Cdk4, Cdk5, Cyclin B1, Cyclin D1, p(27Kip1), phospho-Rb and E2F1) through immunohistochemistry and cell death through TUNEL in autopsy hippocampal tissue samples arrayed in a tissue microarray (TMA) composed of three groups: I) ``clinical-pathological AD{''} (CP-AD) - subjects with neuropathological AD (Braak >= IV and CERAD = B or C) and clinical dementia (CDR >= 2, IQCODE >= 3.8); II) ``pathological AD{''} (P-AD) - subjects with neuropathological AD (Braak >= IV and CERAD = B or C) and without cognitive impairment (CDR 0, IQCODE < 3.2); and III) ``normal aging{''} (N) - subjects without neuropathological AD (Braak <= II and CERAD 0 or A) and with normal cognitive function (CDR 0, IQCODE<3.2). Our results show that high levels of oxidative DNA damage are present in all groups. However, significant reductions in DNA repair and cell-cycle inhibition markers and increases in cell-cycle progression and cell death markers in subjects with CP-AD were detected when compared to both P-AD and N groups, whereas there were no significant differences in the studied markers between P-AD individuals and N subjects. This study indicates that, even in the setting of pathological AD, healthy cognition may be associated with a preserved repair to DNA damage, cell-cycle regulation, and cell death in post-mitotic neurons. (AU)

FAPESP's process: 09/01527-7 - Differentiation between symptomatic and non symptomatic Alzheimer's Disease through the tissue microarray technique in postmortem human brains
Grantee:Aderbal Ruy Teodoro da Silva
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 09/02030-9 - Analysis of DNA damage and expression of tumor suppressor genes in post mortem tissue of patients with Alzheimer's Disease
Grantee:Ana Cecília Feio dos Santos
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 11/01652-6 - Evaluation of symptomatic and asymptomatic Alzheimer's Disease in post-mortem human brains
Grantee:Helena Paula Brentani
Support type: Regular Research Grants